Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07498478 |
| Consolidated Lead Sponsor | TransThera Sciences (Nanjing) |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 94 participants (ESTIMATED) |
| Registered Start Date | 2026-03-17 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Guangdong Provincial People's Hospital | Guangzhou, China | Open Hospital Dossier -> |
| Zhongnan Hospital of Wuhan University | Wuhan, China | Open Hospital Dossier -> |
| Hunan Cancer Hospital | Changsha, China | Open Hospital Dossier -> |
| Jiangsu Province Hospital | Nanjing, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.